Amorolfine : a review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infectionsHARIA, M; BRYSON, H. M.Drugs (Basel). 1995, Vol 49, Num 1, pp 103-120, issn 0012-6667Article

Cisatracurium besilate : A review of its pharmacology and clinical potential in anaesthetic practiceBRYSON, H. M; FAULDS, D.Drugs (Basel). 1997, Vol 53, Num 5, pp 848-866, issn 0012-6667Article

Levofloxacin : a review of its antibacterial activity, pharmacokinetics and therapeutic efficacyDAVIS, R; BRYSON, H. M.Drugs (Basel). 1994, Vol 47, Num 4, pp 677-700, issn 0012-6667Article

Deflazacort : a review of its pharmacological properties and therapeutic efficacyMARKHAM, A; BRYSON, H. M.Drugs (Basel). 1995, Vol 50, Num 2, pp 317-333, issn 0012-6667Article

Epoetin alfa : a review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in nonrenal applicationsMARKHAM, A; BRYSON, H. M.Drugs (Basel). 1995, Vol 49, Num 2, pp 232-254, issn 0012-6667Article

Intranasal fluticasone propionate : a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in allergic rhinitisBRYSON, H. M; FAULDS, D.Drugs (Basel). 1992, Vol 43, Num 5, pp 760-775, issn 0012-6667Article

Cefetamet pivoxil : a review of its antibacterial activity, pharmacokinetic properties and therapeutic useBRYSON, H. M; BROGDEN, R. N.Drugs (Basel). 1993, Vol 45, Num 4, pp 589-621, issn 0012-6667Article

Imipenem/cilastatin : an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infectionsBALFOUR, J. A; BRYSON, H. M; BROGDEN, R. N et al.Drugs (Basel). 1996, Vol 51, Num 1, pp 99-136, issn 0012-6667Article

Propofol : an update of its use in anaesthesia and conscious sedationBRYSON, H. M; FULTON, B. R; FAULDS, D et al.Drugs (Basel). 1995, Vol 50, Num 3, pp 513-559, issn 0012-6667Article

Quinupristin-dalfopristin. A viewpointsBRYSON, H. M; LECLERCQ, R; JOHNSON, C. C et al.Drugs (Basel). 1996, Vol 52, Num 3, pp 406-416, issn 0012-6667Article

Cladribine : a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in haematological malignanciesBRYSON, H. M; SORKIN, E. M.Drugs (Basel). 1993, Vol 46, Num 5, pp 872-894, issn 0012-6667Article

Halofantrine : a review of its antimalarial activity, pharmacokinetic properties and therapeutic potentialBRYSON, H. M; GOA, K. L.Drugs (Basel). 1992, Vol 43, Num 2, pp 236-258, issn 0012-6667Article

Sparfloxacin: A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infectionsGOA, K. L; BRYSON, H. M; MARKHAM, A et al.Drugs (Basel). 1997, Vol 53, Num 4, pp 700-725, issn 0012-6667Article

Itraconazole : A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infectionsHARIA, M; BRYSON, H. M; GOA, K. L et al.Drugs (Basel). 1996, Vol 51, Num 4, pp 585-620, issn 0012-6667Article

Lacidipine : a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertensionRHODA LEE, C; BRYSON, H. M.Drugs (Basel). 1994, Vol 48, Num 2, pp 274-296, issn 0012-6667Article

Dornase alfa : a review of its pharmacological properties and therapeutic potential in cystic fibrosisBRYSON, H. M; SORKIN, E. M.Drugs (Basel). 1994, Vol 48, Num 6, pp 894-906, issn 0012-6667Article

Tizanidine : A review of its pharmacology clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disordersWAGSTAFF, A. J; BRYSON, H. M.Drugs (Basel). 1997, Vol 53, Num 3, pp 435-452, issn 0012-6667Article

Nefazodone : A review of its pharmacology and clinical efficacy in the management of major depressionDAVIS, R; WHITTINGTON, R; BRYSON, H. M et al.Drugs (Basel). 1997, Vol 53, Num 4, pp 608-636, issn 0012-6667Article

Riluzole : A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential is amyotrophic lateral sclerosisBRYSON, H. M; FULTON, B; BENFIELD, P et al.Drugs (Basel). 1996, Vol 52, Num 4, pp 549-563, issn 0012-6667Article

Cabergoline : a review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactationRAINS, C. P; BRYSON, H. M; FITTON, A et al.Drugs (Basel). 1995, Vol 49, Num 2, pp 255-279, issn 0012-6667Article

Foscarnet : a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infectionsWAGSTAFF, A. J; BRYSON, H. M.Drugs (Basel). 1994, Vol 48, Num 2, pp 199-226, issn 0012-6667Article

Ceftazidime : an update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacyRAINS, C. P; BRYSON, H. M; PETERS, D. H et al.Drugs (Basel). 1995, Vol 49, Num 4, pp 577-617, issn 0012-6667Article

Piperacillin/tazobactam : a review of its antibacterial activity, pharmacokinetic properties and therapeutic potentialBRYSON, H. M; BROGDEN, R. N.Drugs (Basel). 1994, Vol 47, Num 3, pp 506-535, issn 0012-6667Article

Porcine-derived lung surfactant : a review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf®) in neonatal respiratory distress syndromeWISEMAN, L. R; BRYSON, H. M.Drugs (Basel). 1994, Vol 48, Num 3, pp 386-403, issn 0012-6667Article

Fosfomycin tromethamine : A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infectionsPATEL, S. S; BALFOUR, J. A; BRYSON, H. M et al.Drugs (Basel). 1997, Vol 53, Num 4, pp 637-656, issn 0012-6667Article